Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Managed Healthcare Industry Analysis

UpdatedApr 05, 2026
DataAggregated Company Financials
Companies11
  • 7D6.5%
  • 3M-19.9%
  • 1Y-43.2%
  • YTDn/a

In the last week, the Managed Healthcare industry is up 6.5%, with UnitedHealth Group up 7.0%. In the past year, the industry is down 43%. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the U.S. Managed Healthcare Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Apr 2026US$376.8bUS$1.0tUS$12.9b18x29.2x0.4x
Tue, 03 Mar 2026US$402.3bUS$1.0tUS$12.9b19.3x31.3x0.4x
Thu, 29 Jan 2026US$397.3bUS$991.6bUS$14.8b18.1x26.9x0.4x
Sat, 27 Dec 2025US$447.5bUS$974.8bUS$20.2b17.1x22.2x0.5x
Mon, 24 Nov 2025US$429.4bUS$974.8bUS$20.1b16.5x21.3x0.4x
Wed, 22 Oct 2025US$486.8bUS$949.6bUS$31.7b14.9x15.4x0.5x
Fri, 19 Sep 2025US$451.2bUS$944.0bUS$31.5b13.8x14.3x0.5x
Sun, 17 Aug 2025US$416.7bUS$943.9bUS$31.5b13x13.2x0.4x
Tue, 15 Jul 2025US$422.6bUS$913.9bUS$34.4b12.7x12.3x0.5x
Thu, 12 Jun 2025US$449.4bUS$913.9bUS$34.4b14.1x13.1x0.5x
Sat, 10 May 2025US$537.1bUS$913.9bUS$34.4b15.5x15.6x0.6x
Mon, 07 Apr 2025US$672.3bUS$887.6bUS$26.1b20.8x25.8x0.8x
Wed, 05 Mar 2025US$610.3bUS$887.6bUS$26.1b20.7x23.4x0.7x
Fri, 31 Jan 2025US$689.7bUS$882.7bUS$25.9b21x26.7x0.8x
Sun, 29 Dec 2024US$647.0bUS$873.5bUS$26.2b18.6x24.7x0.7x
Tue, 26 Nov 2024US$734.6bUS$873.5bUS$26.2b19.2x28x0.8x
Thu, 24 Oct 2024US$717.1bUS$866.7bUS$26.2b16.7x27.3x0.8x
Sat, 21 Sep 2024US$767.5bUS$855.9bUS$26.3b20.6x29.2x0.9x
Mon, 19 Aug 2024US$774.8bUS$855.8bUS$26.3b22x29.5x0.9x
Wed, 17 Jul 2024US$707.8bUS$844.2bUS$27.2b22.3x26x0.8x
Fri, 14 Jun 2024US$692.9bUS$844.2bUS$27.2b20.9x25.4x0.8x
Sun, 12 May 2024US$711.1bUS$844.1bUS$27.2b20.2x26.1x0.8x
Tue, 09 Apr 2024US$648.4bUS$829.6bUS$34.4b19.3x18.8x0.8x
Thu, 07 Mar 2024US$668.6bUS$832.7bUS$33.3b19.5x20.1x0.8x
Sat, 03 Feb 2024US$707.7bUS$830.1bUS$32.9b20.3x21.5x0.9x
Mon, 01 Jan 2024US$726.2bUS$809.0bUS$33.9b20.8x21.4x0.9x
Wed, 29 Nov 2023US$749.7bUS$809.0bUS$33.9b21.7x22.1x0.9x
Fri, 27 Oct 2023US$725.4bUS$805.6bUS$34.2b20.5x21.2x0.9x
Sun, 24 Sep 2023US$703.2bUS$789.4bUS$34.2b21.4x20.6x0.9x
Tue, 22 Aug 2023US$695.5bUS$789.4bUS$34.2b20.4x20.4x0.9x
Thu, 20 Jul 2023US$701.3bUS$784.9bUS$32.6b22.2x21.5x0.9x
Sat, 17 Jun 2023US$650.5bUS$767.3bUS$31.9b20.6x20.4x0.8x
Mon, 15 May 2023US$695.9bUS$767.3bUS$31.9b22.1x21.8x0.9x
Wed, 12 Apr 2023US$733.0bUS$747.4bUS$30.5b23.8x24.1x1x
Price to Earnings Ratio

24.1x


Total Market Cap: US$733.0bTotal Earnings: US$30.5bTotal Revenue: US$747.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Managed Healthcare Industry Price to Earnings3Y Average 22.3x202420252026
Current Industry PE
  • Investors are optimistic on the American Managed Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 29.2x which is higher than its 3-year average PE of 22.3x.
  • The industry is trading close to its 3-year average PS ratio of 0.73x.
Past Earnings Growth
  • The earnings for companies in the Managed Healthcare industry have declined 25% per year over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Managed Healthcare compare with similar industries?

US Market3.46%
Healthcare3.50%
Healthcare Services4.45%
Managed Healthcare6.54%
Healthcare Distributors3.58%
Healthcare Services3.31%
Healthcare Facilities-0.79%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UNH UnitedHealth GroupUS$277.267.0%
+US$16.6b		-47.2%PE20.9x
ELV Elevance HealthUS$300.745.0%
+US$3.2b		-29.9%PE11.7x
CNC CenteneUS$35.119.7%
+US$1.5b		-43.3%PS0.1x
HUM HumanaUS$177.835.2%
+US$1.0b		-29.9%PE18x
ALHC Alignment HealthcareUS$18.7612.9%
+US$437.2m		3.6%PS1x

Latest News

CLOV
US$1.72
Clover Health Investments
7D
-1.7%
1Y
-48.3%

CLOV: CMS Network Interoperability And Execution Improvements Will Support Future Upside

Analysts have trimmed their price target on Clover Health Investments by $0.50. This reflects updated views on fair value and future P/E assumptions following recent research.
MOH
US$139.38
Molina Healthcare
7D
4.0%
1Y
-59.8%

MOH: Elevated Medicaid Acuity And Medical Cost Trends Will Pressure Future Earnings

Molina Healthcare's updated fair value estimate has been reduced from $144.00 to $109.00 as analysts recalibrate price targets, which now range from $128 to $180, to reflect concerns about elevated medical cost trends, Medicaid and exchange acuity pressures, and a reset earnings outlook following a weaker Q4 and revised 2026 guidance. Analyst Commentary Recent Street research on Molina Healthcare reflects a shift toward more cautious views, with a cluster of reduced price targets and a key downgrade following the latest Q4 results and updated 2026 guidance.
PGNY
US$16.60
Progyny
7D
-3.9%
1Y
-26.5%
CNC
US$35.11
Centene
7D
9.7%
1Y
-43.3%

CNC: Government Program Margins In 2026 Will Support Future Earnings Power

Centene's updated analyst price targets show a modest downward reset of about $4 across several firms to a range of roughly $32 to $49, with analysts citing recalibrated valuation multiples, ongoing Medicaid and exchange visibility questions, and mixed readthroughs from recent Q4 results and policy headlines. Analyst Commentary Recent research shows a split view on Centene, with some firms trimming targets and others lifting them, but the common thread is a focus on how Medicaid, exchange membership, and Q4 execution shape the risk and reward profile from here.
ELV
US$300.74
Elevance Health
7D
5.0%
1Y
-29.9%

ELV: 2026 CMS Sanction Clarity Will Drive Medicare Advantage Repricing

Narrative Update The analyst price target for Elevance Health has been reduced by $9.77 to reflect analysts' recalibration of revenue growth and valuation assumptions after recent CMS related headlines. This revision still incorporates company guidance indicating that any sanctions related impact is already captured in 2026 expectations.
ALHC
US$18.76
Alignment Healthcare
7D
12.9%
1Y
3.6%

ALHC: Membership And Retention Trends Will Support Margin Recovery Outlook

Analysts have nudged the average price target for Alignment Healthcare slightly higher to about $25.50, citing updated models that reflect recent target increases across several firms and refinements to growth, margin, and future P/E assumptions. Analyst Commentary Recent Street research on Alignment Healthcare centers on refreshed models and higher price targets, with bullish analysts pointing to membership trends and updated out year estimates as key inputs.
HUM
US$177.83
Humana
7D
5.2%
1Y
-29.9%
HQY
US$84.67
HealthEquity
7D
2.6%
1Y
7.4%
UNH
US$277.26
UnitedHealth Group
7D
7.0%
1Y
-47.2%

UNH: Medicare Advantage Policy Reset Will Support Post 2026 Earnings Recovery

Analysts have made a small adjustment to UnitedHealth Group's outlook, with the average price target moving modestly around the $440 level as they factor in slightly higher long term revenue growth, a marginally stronger profit margin profile, and a slightly lower future P/E assumption following recent sector wide Medicare Advantage commentary and company specific research updates. Analyst Commentary Bullish analysts on UnitedHealth Group are focusing on how recent research updates frame the risk reward around Medicare Advantage and the broader managed care backdrop.